EVAX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $3.20
EPS $-0.81
Revenue $8M
ROE -16.2%
52W Range $3–$12

EVAX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

Stock splits 2
Ex-date Split Type
Jan. 14, 2025 1-for-5 Reverse
Jan. 22, 2024 1-for-10 Reverse

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$8M
2022-12-31 → 2025-12-31
EPS$-0.81
2019-12-31 → 2023-12-31
Free Cash Flow$-7M
2020-12-31 → 2025-12-31
Net margin-102.4%
2023-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

No data for this ratio group yet

Not enough fundamentals data to compute this ratio group yet.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise -58.3%
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Aug 20, 2026 $-0.50 $-0.32 -56.4%
March 31, 2026 May 7, 2026 $-0.50 $-0.31 -61.6%
Dec. 31, 2025 $-1.00 $-0.30 -230.5%
Sept. 30, 2025 $0.50 $0.41 22.5%
June 30, 2025 $-1.00 $-0.67 -48.5%
March 31, 2025 $-0.50 $-0.66 24.6%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 13
Metric Trend 2025202420232022
Revenue $8M$3M$73.0K$0
R&D Expense $10M$10M$12M$17M
SG&A Expense $7M$8M$10M$8M
Operating Income $-9M$-15M$-22M$-25M
Interest Expense $0$0$1.0K$34.0K
Interest Income $5M$6M$963.0K$3M
Pretax Income $-9M$-11M$-23M$-24M
Income Tax $-908.0K$-788.0K$-790.0K$-772.0K
Net Income $-8M$-11M$-22M$-23M
EPS (Basic) $-0.02$-0.20$-0.81$-0.98
EPS (Diluted) ··$-0.81$-0.98
Shares (Basic) 320,406,39153,644,48327,335,82923,638,685
EBITDA $-9M$-15M$-22M$-25M
Balance Sheet 10
Metric Trend 2025202420232022
Cash & Equivalents $23M$6M$6M$13M
Receivables ··$2M$3M
Current Assets $25M$9M$8M$17M
PP&E (Net) $3M$4M$4M$5M
Intangibles $0$0$0·
Total Assets $28M$12M$13M$22M
Current Liabilities $4M$4M$7M$4M
Total Liabilities $11M$14M$18M$14M
Retained Earnings $-126M$-119M$-108M$-86M
Stockholders' Equity $17M$-2M$-5M$8M
Cash Flow 6
Metric Trend 2025202420232022
Operating Cash Flow $-7M$-13M$-18M$-26M
CapEx $11.0K$0$87.0K$292.0K
Investing Cash Flow $-14.0K$-3.0K$-93.0K$-268.0K
Financing Cash Flow $22M$13M$11M$8M
Free Cash Flow $-7M$-13M$-18M$-26M
Levered FCF $-7M$-13M$-18M$-26M
Profitability 7
Metric Trend 2025202420232022
Operating Margin -122.7%-440.6%-30406.8%·
Net Margin -102.4%-316.0%-30308.2%·
Pretax Margin -114.4%-339.6%-31390.4%·
EBITDA Margin -122.7%-440.6%-30406.8%·
ROA -37.7%-83.3%-126.7%-74.5%
ROE -16.2%331.2%-1238.1%-113.7%
ROIC -48.5%829.9%453.2%-294.5%
Liquidity & Solvency 3
Metric Trend 2025202420232022
Current Ratio 5.82.01.24.5
Quick Ratio 5.51.41.14.2
Interest Coverage ··-22197.0-743.1
Efficiency 2
Metric Trend 2025202420232022
Asset Turnover 0.40.30.0·
Receivables Turnover ··0.0·
Per Share 1
Metric Trend 2025202420232022
EPS (TTM) ··$-0.81$-0.98
Valuation (TTM) 4
Metric Trend 2025202420232022
Revenue TTM $8M$3M$73.0K$0
Net Income TTM $-8M$-11M$-22M$-23M
P/E ··-42.3-90.6
Earnings Yield ··-2.4%-1.1%

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $8M $3M $73.0K $0 ·
Operating Margin % -122.7% -440.6% -30406.8% · ·
Net Income $-8M $-11M $-22M $-23M $-25M
Diluted EPS · · $-0.81 $-0.98 $-1.26

Institutional owners (13F) 19 filers · $4.9M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 19
Value held $4.9M
New positions 4
Exited positions 1
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
4 (-1 vs prior Q) 1 (-2 vs prior Q) 2 (0 vs prior Q) 5 (+2 vs prior Q) +49K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
Merck & Co., Inc. $3,763,791 1,214,126 76.29% Shares
Ikarian Capital, LLC $231,564 74,698 4.69% Shares
Rathbones Group PLC $141,741 45,723 2.87% Shares
CITADEL ADVISORS LLC $113,410 36,584 2.30% Shares
RENAISSANCE TECHNOLOGIES LLC $104,780 33,800 2.12% Shares
Annis Gardner Whiting Capital Advisors, LLC $93,000 30,000 1.88% Shares
J. Safra Sarasin Holding AG $70,999 22,896 1.44% Shares
RHUMBLINE ADVISERS $67,723 21,849 1.37% Shares
JANE STREET GROUP, LLC $63,801 20,581 1.29% Shares
BOOTHBAY FUND MANAGEMENT, LLC $57,121 18,426 1.16% Shares
Stonepine Capital Management, LLC $54,442 17,562 1.10% Shares
SmartHarvest Portfolios, LLC $41,726 13,460 0.85% Shares
XTX Topco Ltd $39,987 12,899 0.81% Shares
WESBANCO BANK INC $31,000 10,000 0.63% Shares
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO $24,800 8,000 0.50% Shares
UBS Group AG $19,453 6,275 0.39% Shares
GAMMA Investing LLC $14,297 4,612 0.29% Shares
SBI Securities Co., Ltd. $192 62 0.00% Shares
BESSEMER GROUP INC $0 18 0.00% Shares

EVAX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 10 analysts BUY
Median target $10.00 +212.5%
2 20.0% Strong Buy
7 70.0% Buy
1 10.0% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

4 analysts · 2026-10-01

Mean target $11.25 +251.6%

← Below all targets Current price $3.20
Low$9.00 Mean$11.25 High$16.00

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 20-F filed Mar 5, 2026